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Abstract 
Background: Over the last 10–15 years, a technology has been developed to engineer bacterial poly(3-hydroxybu-
tyrate) (PHB) inclusions as functionalized beads, for applications such as vaccines, diagnostics and enzyme immobili-
zation. This has been achieved by translational fusion of foreign proteins to the PHB synthase (PhaC). The respective 
fusion protein mediates self-assembly of PHB inclusions displaying the desired protein function. So far, beads have 
mainly been produced in recombinant Escherichia coli, which is problematic for some applications as the lipopolysac-
charides (LPS) co-purified with such inclusions are toxic to humans and animals.
Results: In this study, we have bioengineered the formation of functional PHB inclusions in the Gram-positive bac-
terium Bacillus megaterium, an LPS-free and established industrial production host. As B. megaterium is a natural PHB 
producer, the PHB-negative strain PHA05 was used to avoid any background PHB production. Plasmid-mediated T7 
promoter-driven expression of the genes encoding β-ketothiolase (phaA), acetoacetyl-CoA-reductase (phaB) and PHB 
synthase (phaC) enabled PHB production in B. megaterium PHA05. To produce functionalized PHB inclusions, the N- 
and C-terminus of PhaC was fused to four and two IgG binding Z-domains from Staphylococcus aureus, respectively. 
The ZZ-domain PhaC fusion protein was strongly overproduced at the surface of the PHB inclusions and the cor-
responding isolated ZZ-domain displaying PHB beads were found to purify IgG with a binding capacity of 40–50 mg 
IgG/g beads. As B. megaterium has the ability to sporulate and respective endospores could co-purify with cellular 
inclusions, a sporulation negative production strain was generated by disrupting the spoIIE gene in PHA05. This strain 
did not produce spores when tested under sporulation inducing conditions and it was still able to synthesize ZZ-
domain displaying PHB beads.
Conclusions: This study provides proof of concept for the successful genetic engineering of B. megaterium as a host 
for the production of functionalized PHB beads. Disruption of the spoIIE gene rendered B. megaterium incapable of 
sporulation but particularly suitable for production of functionalized PHB beads. This sporulation-negative mutant 
represents an improved industrial production strain for biotechnological processes otherwise impaired by the pos-
sibility of endospore formation.
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Background
Bacteria have been engineered to produce protein or pol-
ymer inclusions in order to efficiently recover proteins of 
interest or to immobilize and/or display various protein 
functions for medical and industrial uses [1–7]. Bacte-
rial inclusions made of the biopolyester, poly(3-hydroxy-
butyrate) (PHB), have been extensively redesigned using 
bioengineering and synthetic biology approaches in 
order to obtain surface functionalized nano-/micro-
spheres. Polyhydroxyalkanoates (PHAs) in general serve 
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as carbon and energy storage. PHB is synthesized from 
the central metabolite acetyl-CoA, requiring consecu-
tive conversions catalysed by three enzymes. The last 
PHB synthesis reaction is catalysed by the PHB Synthase 
(PhaC) which remains covalently bound to the emerging 
PHB granule [8, 9]. The unique underlying self-assembly 
pathway has been harnessed by translationally fusing 
proteins of interest to either terminus of PhaC, which 
ultimately enabled production of PHB beads displaying 
various protein functions [10–16]. This resulted in the 
development of a platform technology for the production 
of functionalized biobeads where a protein of interest is 
displayed at high density and homogenous orientation on 
the bead surface anchored via PhaC [10–13, 16–19]. Pos-
sible applications include diagnostics, affinity biosepara-
tion and vaccine delivery and have been extensively and 
recently reviewed [20–22]. PolyBatics Ltd is using this 
technology to develop and produce a vaccine against 
tuberculosis (TB) and a diagnostic reagent for the detec-
tion of bovine TB [23, 24]. Most of these bead prototypes 
were produced in engineered Escherichia coli. Evidently, 
for medical applications, the use of E. coli as a production 
host can be problematic, as the lipopolysaccharides (LPS) 
synthesized by Gram-negative bacteria have an endo-
toxic effect in humans. The removal of these endotoxins 
during the purification of the PHB beads is considered 
to be laborious and costly. Gram-positive bacteria are a 
promising alternative as they do not contain LPS. Hence 
there is considerable interest to explore these as produc-
ers of various PHAs, both by screening for new strains as 
well as by optimizing established systems [25–30]. How-
ever, these efforts almost exclusively focus on exploit-
ing the organism’s natural ability to generate PHAs and 
the production of PHAs as alternative (bulk) plastics. 
An attempt had previously been made to engineer Lac-
tococcus lactis for the recombinant production of PHB 
beads, including functionalized beads displaying the IgG 
binding domain of Staphylococcus aureus protein A (ZZ-
domain) [16, 31]. Functional beads had been obtained 
but overall PHB yields had been very low suggesting 
that the metabolism of L. lactis is probably not ideal for 
an engineered PHB production pathway. Bacillus mega-
terium, on the other hand, naturally produces PHB [29]. 
It is in fact the organism for which the accumulation of 
PHB was first reported in 1926 [32]. Other advantages of 
this organism include its large cell size (up to 1.5 × 4 μm) 
and the availability of overexpression systems with strong 
promoters [33–35]. For decades B. megaterium has been 
an important industrial workhorse for the production of 
enzymes, vitamins and drugs, and has more recently also 
been considered for the production of recombinant pro-
teins [36–40]. In this study, we were aiming at engineer-
ing B. megaterium for recombinant production of PHB 
towards the assembly of functionalised PHB beads (ZZ 
beads). To avoid a background PHB synthesis, the PHB-
negative strain PHA05 was used as a host. In this strain, 
the PHB synthase encoding genes had been deleted [41]. 
Furthermore, as B. megaterium is capable of sporulation 
[40], there is a risk that, especially if grown to high cell 
densities and under unfavourable conditions, endospores 
are formed. In order to avoid the presence of endospores 
in suspensions of purified biobeads, we investigated the 
possibility to engineer a sporulation-negative PHA05 
strain.
Results
Bioengineering of B. megaterium for production 
of ZZ‑domain displaying PHB beads
The genes phaA, phaB and phaC from Cupriavidus neca-
tor plus the DNA sequences encoding the N- and C-ter-
minally fused Z-domains were synthesized (GenScript) 
as codon optimized for expression in B. megaterium. 
Genes and DNA fragments were inserted into vectors 
pMM1522, p1623hp and pPT7, respectively, in order to 
mediate PHB bead production in B. megaterium (Addi-
tional file 1: Figure S1). In pMM1522 and p1623hp, genes 
are expressed under the control of the xylose-inducible 
xylA promoter [34, 35]. Plasmid p1623hp is a deriva-
tive of pMM1522 with an improved promoter region 
and ribosome binding site. In pPT7 genes are expressed 
under the control of a T7 promoter, and a T7 RNA pol-
ymerase, whose expression is controlled by a xylose-
inducible xylA promoter, is encoded by the plasmid 
pT7RNAP [33]. For both pMM1522 and pPT7, a control 
plasmid was constructed containing only phaA and phaB, 
and one containing phaC, phaA and phaB (in this order) 
to demonstrate production of non-functionalised PHB 
beads. To mediate production of functional PHB beads, 
plasmids containing ZZ/ZZphaC-ZZ (encoding PhaC 
with four N-terminal and two C-terminal Z domains), 
phaA and phaB were made for all three systems. Genes 
phaA and phaB encode the enzymes β-ketothiolase and 
acetoacetyl-CoA-reductase and are required to convert 
acetyl-CoA into hydroxybutyryl-CoA, the substrate of 
PhaC [42]. B. megaterium PHA05 was transformed with 
all plasmids by protoplast transformation.
Optimization of growth medium, growth and induction 
conditions
In recombinant E. coli, PHB beads have routinely been 
produced by growing production strains in glucose-sup-
plemented LB medium. However, growth was unsatis-
factory for B. megaterium PHA05 harbouring either of 
the new production plasmids when grown in LB supple-
mented with various carbon sources (Additional file  1: 
Table S1). The semi-defined A5 medium has previously 
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been used to cultivate B. megaterium [39, 43]. Growth 
and PHB production were assessed for the three pro-
duction systems in A5 medium supplemented with one 
of the following carbon sources: glucose, glycerol, fruc-
tose or pyruvate. Glucose-supplemented A5 medium and 
the T7 system were chosen for further studies as the T7 
system seemed to result in the highest PHB production 
using the various carbon sources (as visually assessed by 
fluorescence microscopy of Nile Red stained cells) and 
glucose addition resulted in the highest  OD600.(Addi-
tional file  1: Table S2). Recombinant E. coli is routinely 
cultivated for 48 h for PHB bead production. However, in 
the case of B. megaterium, measurements of cell density 
 (OD600) and PHB content (GC/MS) indicated that both 
parameters had not increased any further after 48 h com-
pared to 24 h, but instead seemed to decrease, so a stand-
ard cultivation time of 24 h was chosen (Additional file 1: 
Table S3). In order to optimize induction conditions, the 
amount of xylose and the time point of xylose addition 
were also varied. Doubling the amount of xylose added 
or adding xylose again after the initial induction seemed 
to have a slight positive effect of protein overproduction 
(Additional file  1: Figure S2) and on PHB production 
(Additional file 1: Table S4), whereas adding the inducer 
at a higher OD or increasing the glucose concentration 
seemed to be less effective. Subsequent cultures were 
therefore induced by the addition of xylose to a final con-
centration of 1% (w/v) at an  OD600 of 0.4–0.5.
PHB bead isolation and analysis
PHB yields of cultures producing the ZZ-domain PhaC 
fusion were routinely quantified by GC/MS. The PHB 
content was typically in the range of 16–21% of cellu-
lar dry weight (CDW), which was similar to PHB yields 
obtained for PHA05 producing just wild type PhaC. 
Cells producing ZZ-domain displaying beads were also 
assessed by TEM (Fig. 1). PHB beads were then isolated 
from disrupted cells by density gradient centrifugation. 
Up to 2.3 g of beads (wet weight) were obtained from a 
biomass of 25–30 g cells (wet weight) produced per litre 
of culture. Beads were analysed by SDS-PAGE to assess 
the amount of fusion protein present at the bead surface 
(Fig. 2). Figure 2 shows that both PhaC and ZZ/ZZPhaC-
ZZ were strongly overproduced at the bead surface 
(theoretical molecular weights 65 and 118  kDa, respec-
tively). The identity of ZZ/ZZPhaC-ZZ was confirmed 
by MALDI-TOF(MS). Beads were further subjected to 
IgG binding assays, first testing binding and low pH elu-
tion using purified IgG and then by purifying IgG from 
human serum (Fig.  3). Using purified IgG, the beads 
showed a binding capacity of 40–50 mg IgG/g wet beads, 
compared to 60  mg IgG binding to commercial protein 
Fig. 1 Transmission electron microscopic analysis of B. megaterium PHA05 cells containing recombinantly produced PHB beads. The ZZ-domain 
displaying beads were produced from plasmid pPT7-ZZCAB
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A beads. The ZZ-domain displaying PHB beads were also 
shown to successfully purify IgG from human serum as 
shown in Fig.  3. No IgG was eluted from control beads 
not displaying the ZZ-domains.
Generation of a sporulation negative strain
Since B. megaterium is capable of sporulation and since 
spore stains of harvested biomass from PHB bead pro-
duction runs indicated the presence of some spores 
(Additional file 1: Figure S3), it was conceived to gener-
ate a sporulation-negative derivative of PHA05. Look-
ing at early sporulation genes, one could either attempt 
to knock out spo0A, the master regulator for entry into 
spore formation, or a spoII gene [44–46]. SpoIIE has a 
dual role relatively early during the sporulation process 
[35, 36]. It is required for the initial asymmetric cell 
division that determines the fate of the cell while also 
responsible for compartment-specific gene expression 
in the forespore [37, 38]. Hence spoIIE was considered 
as a good target for the inactivation of sporulation while 
retaining physiologically active and viable cells. Initially, 
a knockout by double crossover was attempted following 
the method used to delete the major extracellular pro-
tease of B. megaterium [47]. However, this approach was 
unsuccessful. The spoIIE gene was then inactivated using 
a single crossover technique (Campbell-like integration), 
following the method used by Chen et  al. to generate a 
phaZ1 knockout in B. megaterium (Fig.  4a) [48]. This 
method enables disruption of the target gene through 
integration of the entire plasmid into the genome. B. 
megaterium PHA05 was transformed with gene disrup-
tion plasmid pFRT-Cm-spoIIE and the resulting trans-
formants screened for chloramphenicol resistance. The 
disruption plasmid is based on pUC18 and cannot rep-
licate in B. megaterium; chloramphenicol resistance thus 
indicates genome integration. Chloramphenicol resistant 
colonies were further analysed by PCR and sporulation 
assays. Disruption of the spoIIE gene was confirmed by 
PCR amplification of both ‘genome-plasmid insertion’ 
junctions (Fig. 4b). The PCR product obtained for the 5′ 
junction was sequenced and this further confirmed the 
successful disruption of spoIIE.
Assessment of ΔspoIIE strain in regard to sporulation 
and PHB bead production
The newly generated ΔspoIIE strain was tested for its 
ability to form spores. It was shown to have a sporulation 
negative phenotype under the conditions tested (Table 1). 
In the sporulation assay, cells were first cultivated in liq-
uid or on solid sporulation medium, then heat treated at 
85 °C to kill all vegetative cells and finally dilution plated 
on LB to determine CFUs. To demonstrate that the spor-
ulation medium does indeed promote sporulation, B. 
megaterium PHA05 was grown on this medium and used 
as a positive control. Exponentially growing PHA05 in LB 
was used as a negative control to show that the heat treat-
ment kills non-sporulating cells. In all tests, all ΔspoIIE 
cells were killed by the heat treatment, indicating that by 
inactivating spoIIE a sporulation deficient derivative of B. 
megaterium PHA05 was successfully created.
Due to the presence of a chloramphenicol resistance 
gene within the spoIIE disruption site, the newly gener-
ated sporulation negative strain is currently incompatible 
with the T7 system which relies on the T7 RNA polymer-
ase encoding plasmid pT7-RNAP that mediates resist-
ance to chloramphenicol. Therefore, bead production in 
the new strain was assessed using the xylose inducible 
system based on pMM1522. While the initial plasmid 
constructs for the production of ZZ-domain displaying 
PHB beads were designed to result in an identical amino 
acid sequence to the E. coli system (for better compara-
bility), these constructs still contain the original S. aureus 
Fig. 2 SDS-PAGE of ZZ-displaying and wild type beads recom-
binantly produced in B. megaterium PHA05 under control of the T7 
promoter. Lane 1, ZZ-displaying beads, ZZ/ZZ-PhaC-ZZ protein at one 
asterisk (expected molecular weight 118 kDa); lane 2, wild type beads, 
PhaC protein at two asterisks (expected molecular weight 118 kDa). 
Equal amounts of protein as determined by Bradford were loaded in 
each lane. L, Mark 12™ protein standard (Thermo Fisher Scientific). 
The identity of the ZZ/ZZ-PhaC-ZZ fusion protein was confirmed by 
MALDI-TOF(MS)
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signal sequence (SS). As this might have a more signifi-
cant effect on the Gram-positive host, it was decided to 
remove the SS from pMM-ZZCAB and pT7-ZZCAB. An 
assessment of PHB bead production in B. megaterium 
PHA05 ΔspoIIE was carried out using pMM-ZZCAB(-
SS). Both PHB content (approx. 5% of CDW for both) 
and IgG binding (33 mg/g beads (ΔspoIIE) versus 32 mg/g 
beads (PHA05)) were found to be comparable for the 
ΔspoIIE strain and its parent strain PHA05, indicating 
that the inactivation of spoIIE had no adverse effect on 
the suitability of this strain as a host for the recombinant 
production of engineered PHB beads.
Discussion
In this study, we have explored the possible use of the 
Gram-positive endotoxin-free host B. megaterium for 
the production of functional intracellularly formed PHB 
beads. Here, we present proof-of-concept for the recom-
binant production of PHB in B. megaterium. The main 
focus was on producing functionalised beads such as 
PHB beads displaying the IgG binding ZZ-domain from 
S. aureus. Recombinant production was established in 
the PHB-negative B. megaterium strain PHA05 by intro-
ducing the genes phaC, phaA and phaB, which enable 
PHB biosynthesis from acetyl-CoA, under T7 promoter 
control on plasmid pPT7-CAB or pPT7-ZZCAB. Grow-
ing PHA05 with plasmids pT7-RNAP and pPT7-ZZCAB 
in glucose-supplemented A5 medium, up to 20% PHB of 
CDW was obtained. This is a significant improvement 
compared to engineered Lactococcus lactis which only 
accumulated up to 6% PHB of CDW [31]. As expected, 
the metabolic background of B. megaterium, a natural 
PHB producer, seems to be more suitable for PHB pro-
duction. Higher PHB yields have been achieved in other 
recombinant organisms (e.g. E. coli or Corynebacterium 
glutamicum). In C. glutamicum, which originally reached 
PHB levels around 20%, apart from codon optimization, 
gene dosage made a crucial difference [49, 50]. In par-
ticular the expression levels of phaA and phaB relative to 
phaC were found to be critical. However, C. glutamicum 
was engineered with the aim of producing bulk PHB as a 
biodegradable plastic, whereas in the present study, the 
focus is on producing functionalised PHB beads. More 
important than the overall PHB content is thus a high-
density display of the desired function (e.g. ZZ/ZZPhaC-
ZZ) at the bead surface. The protein profile of purified 
beads (Fig. 2) showed strong overproduction of the ZZ-
domain PhaC fusion protein. This was also reflected by 
an IgG binding capacity and purification power which 
resembled the performance of commercially available 
protein A beads (Fig. 3).
To exclude the possibility of sporulation and potential 
co-purification of spores with the beads, an improved 
B. megaterium bead production host was engineered by 
generating a sporulation-negative derivative of PHA05. 
Another sporulation-negative B. megaterium strain has 
previously been published [51]. However, in this strain 
the spoIV gene (stage IV =  spore cortex synthesis) had 
been deleted, which still enables formation of pre-spores 
that still could co-purify with inclusions such as PHB 
Fig. 3 IgG binding assays using a purified IgG and b human serum. F, feed [IgG (a) or human serum (b)]; U unbound, E elution, CAB control beads 
not displaying ZZ domain, ZZ ZZ-domain displaying beads produced in this study, GE commercially available GE protein A beads; L, Mark 12™ 
protein standard (Thermo Fisher Scientific). Beads were incubated with the respective feed material, washed repeatedly and IgG eluted with glycine 
pH 2.7. Asterisks indicate the IgG light and heavy chains
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Fig. 4 a Overview of spoIIE disruption by single crossover (Campbell-like integration) and b confirmation of spoIIE disruption by PCR amplification. 
a The constructed plasmid unable to replicate in the host organism is depicted. It contains a section of the target gene (between FRT sites) plus a 
selectable marker  (CmR). Homologous recombination occurs between the gene fragment on the plasmid and the identical gene segment on the 
chromosome followed by genome integration of the entire plasmid. The target gene is ‘insertionally inactivated’, i.e. disrupted by splitting it into a 
truncated forward and rear end (with the homologous gene sequence present twice in the altered genome). b Amplification across each junction 
was done using one primer binding in the genome and one primer binding within the integrated plasmid-derived fragment. 5′ a, amplification 
across 5′ junction using primers spo5′fwd2 and CmF (1.9 kb product); 5′ b, amplification across 5′ junction using primers spo5′fwd3 and Cm_pMK_
inner_fwd2 (1.2 kb product); 3′, amplification across 3′ junction using primers M13 fwd and spo3′rev2 (2.3 kb product); ΔE, spoIIE knockout strain; C, 
B. megaterium PHA05 wild type control; P, plasmid control (pFRT-Cm-spoIIE). For supplemental confirmation, the PCR product obtained with primers 
spo5′-fwd2 and CmF was sequenced. L, ladder λ PstI (PstI digested λ DNA)
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beads. In addition, the existing ΔspoIV strain is not PHB-
negative. In order to avoid pre-spore formation, we con-
sidered early stage sporulation genes such as spo0A or 
one of the spoII genes [44–46]. The spo0A gene encodes 
a master regulator that regulates other genes which in 
turn regulate post-exponential gene expression (e.g. 
prevent certain stationary phase functions from being 
expressed during exponential phase) [52–55]. Hence 
deleting spo0A could have unpredictable and undesired 
side-effects. Spo0A directly regulates several stage II 
sporulation genes such as the spoIIA and spoIIG oper-
ons (encoding sigma factors F and E) as well as spoIIE 
[44]. SpoIIE has been labelled the ‘cell fate determinant’ 
[56], a name that reflects its crucial role during the early 
stages of sporulation. It is a bifunctional protein involved 
first in asymmetric cell division and then in forespore-
specific gene expression via sigma F activation [57–60]. 
When spoIIE was mutated in Bacillus subtilis, sporula-
tion did not occur. Asymmetric cell division (due to FtsZ) 
still happened but in a lower percentage of cells [58]. In 
a Clostridium acetobutylicum spoIIE disruption strain, 
sporulation was even blocked prior to asymmetric divi-
sion and no morphogenetic changes were observed [61]. 
Interestingly, Bi et al. also had difficulties inactivating the 
C. acetobutylicum spoIIE gene by double crossover and 
only achieved the disruption by single crossover [61]. For 
this study, it was irrelevant whether asymmetric cell-divi-
sion still occurred in the mutant or not. Thus, the spoIIE 
gene was considered as a suitable target for inactivation. 
Here, the spoIIE gene was disrupted in the PHB-negative 
strain B. megaterium PHA05 (Fig. 4), abolishing the abil-
ity to sporulate as shown by 100% killing after heat treat-
ment in the sporulation assays (Table  1). Unfortunately, 
attempts to remove the chloramphenicol resistance gene 
from the knockout via the flanking FRT sites have so far 
been unsuccessful. Therefore, the ΔspoIIE strain is cur-
rently incompatible with the T7 expression system as 
pT7RNAP contains a  CmR cassette. The strain’s ability 
to sustain the production of functionalized (ZZ-domain 
displaying) PHB beads was thus preliminarily assessed 
using the xylose-inducible system based on pMM1522 
[pMM-ZZCAB(-SS)]. Both PHB content and IgG binding 
performance were comparable for ΔspoIIE and its parent 
strain PHA05, suggesting that the spoIIE gene disruption 
had no adverse effect on growth or PHB production.
In addition to restoring compatibility of the T7 system 
with the spoIIE disruption strain, possible approaches 
to enhance productivity and performance could include 
gene dosage and additional Z-domains. In C. glutami-
cum, increasing the copy number of phaA and phaB 
(by supplying an additional copy on a second plasmid 
in addition to the plasmid bearing phaC, phaA and 
phaB) significantly increased PHB yield [50]. In E. coli, 
on the other hand, high PHB yields have routinely been 
obtained by expressing phaC under T7 promoter con-
trol and phaA and phaB under lac promoter control 
[16, 62]. Recently, Hooks et al. identified regions within 
PhaC that tolerated insertions, e.g. of ZZ-domains [63]. 
Some of the newly created ZZ-domain PhaC fusions 
exhibited improved IgG binding. These strategies could 
be explored to increase PHB bead production and the 
density of ZZ-domains displayed at the bead surface in 
order to improve cost-effectiveness of production as well 
as PHB bead performance when using B. megaterium 
PHA05 ∆spoIIE.
Conclusions
This study demonstrates the successful genetic engi-
neering of B. megaterium as a host for the production 
of functionalized PHB-based biobeads. ZZ-domain 
Table 1 Sporulation assays
a Positive control: B. megaterium PHA05 wild type, sporulates on/in sporulation medium
b Negative control: exponentially growing B. megaterium PHA05 wild type (in LB)
c 85 °C had been experimentally determined to be the optimum temperature for this assay (all vegetative cells killed, spores survive)
Strain Time at 85 °C (min)c From liquid culture From solid medium From solid medium
CFU/mL Control (30 min 25 °C) CFU/mL Initial culture CFU/mL Initial culture
Positive control (WT spo)a 30 1.6 × 105 3.0 × 106 2.1 × 105
45 2.2 × 105 1.2 × 107 7.1 × 105 1.6 × 106 2.3 × 105 4.5 × 106
60 1.7 × 105 9.6 × 104 2.3 × 105
ΔspoIIE 30 0 0 0
45 0 2.4 × 106 0 8.5 × 106 0 1.6 × 106
60 0 0 0
Negative control (WT exp)b 30 0 0 0
45 0 3.2 × 106 0 8.7 × 105 0 2.1 × 106
60 0 0 0
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displaying PHB beads suitable for purification of 
IgG from human serum were produced. Functional 
PHB bead production was mediated by T7 promoter-
dependent expression of relevant genes in the PHB-
negative strain PHA05. As sporulation occurred 
during PHB bead production a sporulation negative 
derivative of PHA05 was generated by disruption of 
the spoIIE gene. The sporulation- and PHB-negative 
B. megaterium strain generated in this study, repre-
sents an industrial host suitable for the production of 
intracellular products such as functional PHB beads 
or inclusion bodies.
Methods
Plasmids, DNA constructs and oligonucleotides
All plasmids are listed in Table 2. All oligonucleotides are 
listed in Additional file  1: Table S5. To make the PHB-
production plasmids, genes were synthesized with their 
sequence optimized for Gram-positive codon usage. The 
ZZ/ZZC-ZZ encoding sequences were designed to trans-
late into a protein with identical amino acid sequence 
compared to the E. coli produced protein [16]. phaC, 
phaA, phaB, the N-terminal Z domains and the C-ter-
minal Z domains were all synthesized individually by 
GenScript and provided in plasmid pUC57. Restriction 
Table 2 Strains and plasmids used in this study
Strain/plasmid name Genotype/description Source/references
Strain
 E. coli XL1BLue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F′ proAB lacIqlacZ ΔM15 Tn10 (TetR)] Stratagene
 B. megaterium PHA05 PHA-negative mutant of 11561 (ATCC); Δ(phaP-phaC);  Emr [41]
 B. megaterium PHA05 
ΔspoIIE
Sporulation-negative mutant of PHA05; Δ(phaP-phaC) ΔspoIIE;  EmR  CmR This study
Plasmid
 pUC57-phaA Codon optimized phaA in pUC57,  AmpR GenScript
 pUC57-phaB Codon optimized phaB in pUC57,  AmpR GenScript
 pUC57-phaC Codon optimized phaC in pUC57,  AmpR GenScript
 pUC57-ZZ/ZZ Codon optimized N-terminal Z domains in pUC57,  AmpR GenScript
 pUC57-ZZ Codon optimized C-terminal Z domains in pUC57,  AmpR GenScript
 pMM1522 Shuttle vector for cloning in E. coli  (AmpR) and expression under xylose control in B. megaterium 
 (TetR)
[34]
 pMM-AB Codon optimized phaA and phaB cloned BglII-BamHI and BamHI-KpnI, respectively, into 
pMM1522
This study
 pMM-CAB Codon optimized phaC cloned BsrGI-BglII into pMM-AB This study
 pMM-ZZCAB ZZ/ZZC-ZZ cloned BsrGI-BglII into pMM-CAB, replacing phaC This study
 pPT7 Shuttle vector for cloning in E. coli  (AmpR) and expression in B. megaterium  (TetR). T7 promoter 
and terminator inserted to give  PT7-MCS-Stop-TT7
[33]
 pPT7-AB phaAB fragment from pMM-AB cloned BglII-KpnI into pPT7 This study
 pPT7-CAB phaCAB fragment from pMM-CAB cloned BsrGI-KpnI into pPT7 This study
 pPT7-ZZCAB ZZ/ZZC-ZZ cloned BsrGI-BglII into pPT7-CAB, replacing phaC This study
 pT7RNAP Helper plasmid bearing T7 RNA polymerase under control of xylA promoter  (CmR) [33]
 p1623hp (=p3STOP1623hp) Shuttle vector for cloning in E. coli  (AmpR) and expression under xylose control in B. megaterium 
 (TetR)
[35]
 p1623-ZZCAB ZZ/ZZCZZ-AB fragment from pMM-ZZCAB cloned BsrGI-KpnI into p1623hp This study
 pPT7-ZZCAB(-SS) N-terminal ZZ/ZZ region PCR amplified (without SS) from pPT7-ZZCAB and re-inserted into pPT7-
CAB; C-terminal Z domains sucloned Bsu361-KpnI from pPT7-ZZCAB
This study
 pMM1522PacI G-block fragment ‘SalI-part of xylR-PxylA-PacI-SpeI’ inserted SalI-SpeI into pMM1522 This study
 pMM-ZZCAB(-SS) ZZ/ZZC-ZZ-AB fragment subcloned PacI-KpnI from pPT7-ZCAB(-SS) to give pMM-ZCAB(-SS) This study
 pUC18 E. coli cloning vector,  AmpR. No origin of replication for B. megaterium Thermo scientific
 pMK-RQ-Cm Gene synthesis of chloramphenicol resistance gene, flanked by FRT sites (FRT-CmR-FRT) in pMK-
RQ,  KanR
GeneArt
 pUC18-FRT = pFRT FRT sites (amplified from pMK-RQ-Cm (synthesis of FRT-CmR-FRT)) cloned HindIII-FRT-BamHI-FRT-
KpnI into pUC18
This study
 pFRT-Cm CmR gene PCR amplified from pMK-RQ-Cm with primers Cm-Fpsc and Cm-Rpsc (introducing SacI 
sites) and cloned SacI into pFRT
This study
 pFRT-Cm-spoIIE 500 nt fragment of B. megaterium spoIIE gene PCR amplified with primers SpoF-psc (NheI) and 
SpoR-psc (ApaI) and cloned NheI-ApaI into pFRT-Cm
This study
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sites for cloning were included in the gene synthesis. To 
generate plasmid pMM-AB, pUC57-phaA and pUC57-
phaB were digested BglII-BamHI and BamHI-KpnI, 
respectively, and the genes phaA and phaB ligated into 
BglII-KpnI digested vector pMM1522 (Table  2) [34]. 
pUC57-phaC and pMM-AB were then digested BsrGI-
BglII and phaC ligated into pMM-AB to result in plas-
mid pMM-CAB. To generate plasmid pMM-ZZCAB, 
the N-terminal Z domains were excised from pUC57 
with BsrGI and PciI and ligated into BsrGI-NcoI digested 
pUC57-phaC. The resulting plasmid was digested BsrGI-
Bsu361, pUC57 containing the C-terminal Z domains 
was digested Bsu361-BglII, and the resulting two frag-
ments ZZ/ZZ-phaC(5′) and phaC(3,)-ZZ were ligated 
into BsrGI-BglII digested plasmid pMM-CAB, thereby 
replacing phaC with ZZ/ZZphaC-ZZ. pPT7-AB and 
pPT7-CAB were generated by cloning the respective 
fragments AB and CAB from pMM-AB and pMM-CAB 
into pPT7 (BglII-KpnI and BsrGI-KpnI, respectively) 
[33]. pPT7-ZZCAB was constructed in the same way 
as described above for pMM-ZZCAB (replacing phaC 
with ZZ/ZZphaC-ZZ). p1623-ZZCAB was generated by 
cloning the entire ZZ/ZZC-ZZ-AB fragment of pMM-
ZZCAB BsrGI-KpnI into p1623hp [35].
To remove the sequence for the N-terminal signal 
peptide of the Z domains, a PacI restriction site was 
inserted into plasmid pMM1522 upstream of the origi-
nal RBS: A 500  bp fragment comprising SalI—part of 
xylR–PxylA–PacI–SpeI was designed and ordered as a 
G-block from IDT. This region was then cloned SalI-SpeI 
into pMM1522, generating pMM1522PacI. The entire 
ZZ/ZZC-ZZ-AB fragment of pPT7-ZZCAB(-SS) was 
then subcloned PacI-KpnI into pMM1522PacI to give 
pMM-ZZCAB(-SS). To generate pPT7-ZCAB(-SS), the 
N-terminal ZZ/ZZ containing region was amplified from 
the original pPT7-ZZCAB with primers ZZ-fwd-noSS 
and ZZ-rev-BspEI and re-inserted into pPT7-CAB (PacI, 
BspEI). The C-terminal Z domains were added by sub-
cloning the C-terminal region of ZZ/ZZphaC-ZZ from 
pPT7-ZZCAB Bsu361-BglII into the above plasmid.
To generate the single crossover spoIIE disruption vec-
tor starting from pUC18, a DNA fragment comprising 
FRT-CmR-FRT was synthesized by GeneArt (pMK-RQ-
Cm). The FRT sites were PCR amplified with primers that 
inserted restriction sites (FRT-1Fpsc (HindIII) and FRT-
1Rpsc (BamHI) or FRT-2Fpsc (BamHI) and FRT-2Rpsc 
(KpnI)) and then cloned into pUC18 HindIII-BamHI and 
BamHI-KpnI, respectively, resulting in pFRT. The  CmR 
gene was then also PCR amplified from pMK-RQ-Cm 
(with primers CmF-psc and CmR-psc (introducing SacI 
sites)) and cloned SacI into pFRT, resulting in pFRT-Cm. 
Finally, a 500-nucleotide-fragment of the B. megaterium 
spoIIE gene was PCR amplified (with primers SpoF-psc 
(NheI) and SpoR-psc (ApaI)) and cloned NheI-ApaI 
into pFRT-Cm, generating the spoIIE disruption vector 
pFRT-Cm-spoIIE.
Bacterial strains and growth conditions
All strains are listed in Table  2. E. coli was routinely 
grown in LB medium at 37 °C. B. megaterium was grown 
in LB at 37 °C or—for PHB production—A5 medium sup-
plemented with 2% (w/v) glucose. For PHB production, B. 
megaterium bearing the relevant plasmid(s) was initially 
cultivated at 37  °C, induced by the addition of xylose to 
a final concentration of 0.5% (w/v) or 1% (w/v) at  OD600 
of 0.4–0.5, and then cultivated at 25 °C for another 24 h.
A5 medium (modified from [39, 43]): 2  g/L 
 (NH4)2SO4, 3.52  g/L  KH2PO4, 5.683  g/L  Na2HPO4, 
0.3  g/L Mg  SO4·7H2O, 1  g/L yeast extract, 1  mL/L 
trace element stock solution [added after autoclav-
ing), 100  mL/L glucose (20% (w/v)] (added after 
autoclaving). Trace element stock solution (filter steri-
lized): 40  g/L  MnCl2·4H2O, 53  g/L  CaCl2·2H2O, 2  g/L 
 (NH4)6MO7O24·4H2O, 2  g/L  CoCl2·6H2O, 2.5  g/L 
 FeSO4·7H2O.
Antibiotics Ampicillin (75 μg/mL for E. coli), chloram-
phenicol (4.5 μg/mL) and tetracycline (10 μg/mL).
Sporulation medium (modified from [64]): 3  g/L 
beef extract, 5  g/L peptone, 1  g/L KCl, 10  mL/L of 2% 
 MgSO4 × 7H2O, pH 7–7.5; after autoclaving, add: 1 mL 
of 1 M  CaCl2 × 2H2O, 100 μL of 0.1 M  MnCl2 × 4H2O, 
100 μL of 10 mM  FeSO4 × 7H2O; used as liquid medium 
and agar plates. Strains were grown in liquid or on solid 
sporulation medium at 37 °C for one or 2 days. A colony 
or an aliquot of a cell pellet was resuspended in 50 μL of 
sterile water or Tris buffer, heated to 85 °C for 30, 45 or 
60 min and spotted on LB plates.
Transformation procedures
Escherichia coli was transformed by heat shock of chemi-
cally competent cells as described previously [65]. B. 
megaterium was transformed by protoplast transforma-
tion following the protocols published by Barg et al. and 
Biedendieck et al. [36, 66].
Isolation of polymer beads
PHB beads were isolated as described previously with 
modifications to allow for the new host and new plas-
mid system [31, 62]. B. megaterium PHA05 containing 
plasmids pT7-RNAP  (CmR) and pPT7-ZZZZCZZ-AB 
 (TetR) (or one of the other plasmid systems, with the 
respective antibiotics) was cultivated in A5 medium 
with 10 μg/mL tetracycline and 4.5 μg/mL chloram-
phenicol at 37 °C. At  OD600 of 0.4–0.5, protein produc-
tion was induced by addition of xylose (0.5 or 1% final 
concentration) and the cultures were shifted to 25  °C. 
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After 24 h of growth cells were harvested by centrifuga-
tion. After resuspension in 50 mM phosphate buffer (pH 
7.4) cells were disrupted by lysozyme treatment (30 min 
at 37  °C) and cell disruptor passage (2 passages at 30 
kpsi). Following centrifugation and resuspension of the 
pellet (crude beads) in phosphate buffer, the material 
was loaded onto an 88 and 44% (vol/vol) glycerol gra-
dient and subjected to ultracentrifugation at 100.000×g 
for 2 h. Beads were retrieved from the interface between 
the 88 and 44% glycerol layers.
Staining techniques
In order to visualize PHB inclusions inside B. megaterium 
cells for a quick assessment of PHB production, cells were 
stained with the lipophilic dye Nile Red. 100 µL of culture 
were pelleted by centrifugation, the pellet washed with 
and resuspended in 1 mL of potassium phosphate buffer 
(pH 7.4) and 10 µL of a Nile Red stock solution (250 µg/
mL in DMSO) added. After incubation in the dark at 
room temperature for 5–15  min, cells were washed to 
remove exess Nile Red, mounted on microscope slides 
and examined under the fluorescene microscope (Olym-
pus BX51 Microscope).
Bacterial endospores were stained with malachite 
green. Briefly, a resuspended culture aliquot was smeared 
on a microscope slide and briefly left to air dry. The 
smear was then flooded with malachite green and the 
dye heat fixed. Excess dye was washed off with water, and 
vegetative cells were counterstained with aqueous safra-
nin for 30 s. Excess dye was again washed off, slides care-
fully blotted dry and observed under the oil immersion 
(Zeiss Axiophot Microscope). All microscopy was done 
at the Manawatu Microscopy and Imaging Centre (Palm-
erston North, New Zealand).
Transmission electron microscopy (TEM) analysis
To confirm PHB bead formation inside recombinant 
B. megaterium and to visually assess the beads, TEM 
analysis was performed at the Manawatu Microscopy 
and Imaging Centre (Palmerston North, New Zealand). 
After 24 h of growth, cells were harvested, washed with 
50 mM potassium phosphate buffer (pH 7.4), and sedi-
ments were prepared for TEM as described previously 
[62].
PHA quantification by gas chromatography/mass 
spectrometry (GC/MS)
In vivo activity of the polyester synthase was obtained by 
analysing the polyester content of the respective bacterial 
cells. PHA content of the lyophilized cells was quantified 
using gas chromatography-mass spectrometry (GC/MS) 
after conversion of the PHA into 3-hydroxymethylester 
by acid-catalyzed methanolysis [67].
Protein analysis
Protein samples (including bead-bound proteins) were 
routinely analysed by SDS-PAGE (sodium dodecyl sul-
phate-polyacrylamide electrophoresis) as described 
elsewhere [68]. The gels were stained with Coomas-
sie brilliant blue G250. Protein concentrations were 
determined using the Bio-Rad Protein Assay. Dominant 
bands were excised from the gel and identified by matrix-
assisted laser desorption ionization-time of flight (mass 
spectrometry) [MALDI-TOF(MS)] as described previ-
ously [15].
IgG binding assays
The IgG binding performance (binding capacity and 
purification power) of purified ZZ-displaying beads was 
assessed and quantified by two types of assays as previ-
ously described: binding and elution of purified IgG and 
purification of IgG from human serum [14, 31]. Briefly, 
a defined amount of beads was incubated with the feed 
material (IgG or serum), subjected to a series of washes 
and bound IgG eluted with glycine pH2.7. Elution frac-
tions were assessed by SDS-PAGE analysis.
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